Hasta la vista, maybe? Terminating the Hollywood view of AI in pharma
Marketing Director Julie Denny was recently interviewed by PME Magazine about the use of artificial intelligence in pharma marketing and market research.
Rumours that robots will eventually wipe out humans are the futuristic stuff of Hollywood blockbusters. The real-world story arc is much more uplifting but no less dramatic. When a homeless man in central England was crushed to death by a compaction unit as he slept in the dustbin in 2013, it triggered a response from the UK waste management industry that now sees many refuse trucks fitted with senor technology to detect people in bins. It's an early example of how AI can literally save lives. Fast forward six years and we've now got 'robot doctors' detecting cancers, smart remote monitoring systems managing patients miles from their homes and algorithm-led technologies predicting long-term health based on individuals' DNA. The application of AI in health isn't science fiction, it's happening fast - and it’s positively disrupting patient care.
Fast and furious: What will the fast tracking of approvals for key drugs mean for China's pharma market?
China has long been a magnet for pharmaceutical multinationals looking to offset flattening growth in established markets
It offers rapid economic development, a population of around 1.4 billion with limited access to cutting-edge medicine, and changing lifestyles that have raised health expectations. Expanded access to state-funded healthcare, population aging and a growing burden of chronic disease are creating new opportunities for innovative drugs alongside low-cost generics.
Research Partnership sends a cheque for $10,000 to Forever Angels
Helping them in their mission of caring for and improving the lives of orphans and abandoned infants in Tanzania
The Forever Angels baby home has, for the past 10 years, taken in and cared for hundreds of young children in Tanzania. In the last year alone, Forever Angels has received 20 new children into their care, seen 11 children adopted into new homes and helped return 8 children to their biological families.
Patient centricity: Reality or rhetoric?
Everybody is talking about patient centricity, but what does it mean for those involved in market research, insights and business intelligence?
The term has certainly begun to filter through to the pharmaceutical market research industry. It was a hot topic at EphMRA conference in 2017, with a number of presentations from agencies, including some innovative new research offerings.
How facial analysis was used to evaluate the emotional impact of a disease promotion campaign
Our client had developed a visual and emotion-invoking, online disease awareness campaign aimed at challenging physicians’ current perceptions of treatment. Research was required to understand physicians’ reactions to the campaign (rational and emotional) and whether it would have the desired effect of increasing use of their treatment in the future, to help encourage the client’s local operating companies to adopt and roll out the campaign.